Healthcare RCM M&A Insights Report

The CAS 2025 Healthcare RCM Report delivers a comprehensive, data-driven analysis of the healthcare revenue cycle management landscape as we move into 2026.

Inside the report, CAS explores:

• Why the Healthcare RCM market remains seller-favorable, supported by sustained sponsor demand and ongoing consolidation
• A detailed breakdown of M&A and capital raise activity, including the continued shift toward add-on acquisitions to scale existing platforms
• How AI deployment across the revenue cycle — particularly in denials prevention, coding, and upstream workflows — is reshaping vendor positioning
• The growing impact of provider margin pressure, rising healthcare spending, and labor constraints, reinforcing long-term outsourcing demand
• Key regulatory developments across CFPB, CMS, and ACA/Medicaid changes that are increasing front-end complexity and denial risk
• The broader macroeconomic backdrop, including inflation, interest rate trends, and sponsor dry powder heading into 2026

Backed by proprietary transaction data and deep sector expertise, this report offers actionable insight for RCM operators, healthcare technology providers, private equity sponsors, and strategic acquirers evaluating opportunities in 2026. Click here to read the full report.